Anthracycline based chemotherapies could have greater negative effects on cognition than nonanthracycline treatments for breast cancer survivors, a new study reports.
Researchers have shown that infrared and Raman spectroscopy – coupled with statistical analysis – can be used to tell the difference between normal brain tissue and the different tumor types that may arise in this tissue, based on its individual biochemical-cell ‘fingerprint’.
Using nanoparticles, researchers have discovered a way to target difficult to reach cancers.
Patients who experience chemobrain after treatment for cancer show brain network disruptions, researchers report.
Researchers have developed a new 3D printing technique which can produce brain tumor cells that continue to grow rapidly and mimic the growth of real glioma tumors.
Researchers have discovered a protein that helps map the edges of brain tumors so they show up more clearly on MRI scans.
Researchers have developed a new method for creating custom tailored, two stage therapies for glioblastoma brain cancer.
Researchers have created new 3D maps of two melatonin receptors. The models can be used to help develop new treatments that not only improve sleep, but may also treat a variety of other conditions from diabetes to cancer.
Researchers have developed a new experimental approach to treating medulloblastoma brain cancer.
A new computational model predicts how information deep inside the brain could flow from one network to another, and how neural network clusters can self optimize over time.
Study shows how cholesterol becomes dysregulated in brain cancer cells and reports the gene responsible for the dysregulation could be a potential target to help treat glioblastoma brain cancer.
New findings could provide additional insight into the cause of glioblastoma and provide new options for personalized therapeutic treatments.
